LFSTLifeStance Health Group, Inc.

Nasdaq lifestance.com


$ 5.70 $ -0.10 (-1.72 %)    

Friday, 24-May-2024 15:59:56 EDT
QQQ $ 454.82 $ 4.29 (0.95 %)
DIA $ 398.57 $ -0.02 (-0.01 %)
SPY $ 530.36 $ 3.48 (0.66 %)
TLT $ 91.26 $ 0.27 (0.3 %)
GLD $ 225.37 $ 0.20 (0.09 %)
$ 5.7
$ 5.88
$ 0.00 x 0
$ 0.00 x 0
$ 5.67 - $ 5.99
$ 4.74 - $ 9.59
3,420,910
na
2.15B
$ 1.56
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 03-09-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-10-2022 06-30-2022 10-Q
9 05-11-2022 03-31-2022 10-Q
10 03-17-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-lifestance-health-group-lsft-stock-is-falling

LifeStance Health shares are trading lower by 19.8% during Wednesday's session. The company announced pricing of a 20 milli...

 reported-earlier-lifestance-health-group-prices-secondary-public-offering-of-20m-common-shares-at-625share

The Selling Stockholders will receive all of the proceeds from the offering. The Company is not selling any shares of Common St...

 lifestance-health-reiterated-fy24-revenue-of-119b-124b-vs-122b-est

2024 Guidance LifeStance is providing the following outlook for 2024: The Company is reiterating full year revenue of $1.19...

 lifestance-health-expects-q2-revenue-of-297m-315m-vs-30498m-est

2024 Guidance LifeStance is providing the following outlook for 2024: The Company is reiterating full year revenue of $1.19...

 lifestance-health-gr-q1-2024-gaap-eps-006-beats-008-estimate-sales-300437m-beat-298991m-estimate

LifeStance Health Gr (NASDAQ:LFST) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of ...

 revenue-down-margins-up-lifeists-q1-financial-results-show-focus-on-premium-products-curbed-revenue-drop

Lifeist Wellness' Q1 2024 financial results, highlight a strategic shift towards higher-margin products and improved effici...

 morgan-stanley-reiterates-overweight-on-lifestance-health-gr-maintains-10-price-target

Morgan Stanley analyst Ricky Goldwasser reiterates LifeStance Health Gr (NASDAQ:LFST) with a Overweight and maintains $10 pr...

 lifeist-reports-highest-quarterly-gross-profit-in-history-continues-to-diversify-its-wellness-business

Lifeist Wellness Inc. reported on Monday its financial results for the three and 12 months ended Nov. 30, 2023. The Toronto-bas...

 jefferies-maintains-buy-on-lifestance-health-gr-raises-price-target-to-9

Jefferies analyst Brian Tanquilut maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $...

 goldman-sachs-maintains-neutral-on-lifestance-health-gr-raises-price-target-to-9

Goldman Sachs analyst Jamie Perse maintains LifeStance Health Gr (NASDAQ:LFST) with a Neutral and raises the price target fr...

 why-bumble-shares-are-trading-lower-by-12-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.

 why-is-behavioral-health-focused-lifestance-health-stock-trading-higher-thursday

LifeStance Health reports 22% jump in Q4 2023 revenue of $280.60 million. Clinician base expands by 18%, visit volumes increase...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION